Header Logo

Connection

KARTHIK VADAMALAI to Rituximab

Back to Details
This is a "connection" page, showing publications KARTHIK VADAMALAI has written about Rituximab.
KARTHIK VADAMALAI
Connection Strength
0.158
Rituximab
  1. The Use of 20% Subcutaneous Immunoglobulin Replacement Therapy in Patients With B Cell Non-Hodgkin Lymphoma With Humoral Immune Dysfunction After Treatment With Rituximab. Clin Lymphoma Myeloma Leuk. 2020 09; 20(9):e590-e596.
    View in: PubMed
    Score: 0.158
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.